Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 291

    IHH says Fortis board declines to engage on takeover offer

    IHH says Fortis board declines to engage on takeover offer

    Ruby Khatun Khatun17 April 2018 10:30 AM IST
    Mumbai: Malaysia’s IHH Healthcare Bhd said on Monday India’s Fortis Healthcare Ltd declined to engage with the company regarding a takeover offer,...
    Government should allow same level of operational freedom to its experts in procurement in healthcare as it has in defence: MTaI

    Government should allow same level of operational freedom to its experts in procurement in healthcare as it has in defence: MTaI

    Ruby Khatun Khatun17 April 2018 10:15 AM IST
    New Delhi: Medical Technology Association of India (MTaI), which represents leading research-based medical technology companies with significant...
    Bristol-Myers says cancer drug combo reduces death risk

    Bristol-Myers says cancer drug combo reduces death risk

    Ruby Khatun Khatun17 April 2018 10:00 AM IST
    Bristol-Myers Squibb said on Monday its cancer drugs, Opdivo and Yervoy, reduced the risk of the disease spreading or death in previously untreated...
    Google unveils vetting process for drug rehab ads

    Google unveils vetting process for drug rehab ads

    Ruby Khatun Khatun17 April 2018 9:45 AM IST
    SAN FRANCISCO: Google told Reuters it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc...
    Johnson and Johnson Baby Powder litigation takes new focus with asbestos claims

    Johnson and Johnson Baby Powder litigation takes new focus with asbestos claims

    Ruby Khatun Khatun17 April 2018 9:30 AM IST
    NEW YORK: A $117 million verdict against Johnson and Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by...
    Cipla arm recalls multiple lots of antidepressant drug from US

    Cipla arm recalls multiple lots of antidepressant drug from US

    Ruby Khatun Khatun16 April 2018 10:30 AM IST
    New Delhi: Pharma major Cipla's arm InvaGen Pharmaceuticals Inc is recalling 11 lots of antidepressant bupropion HCl extended-release tablets from the...
    Next Gen Pharma launches Roidosanal for treatment of Haemorrhoids, Backed with Clinical Studies

    Next Gen Pharma launches Roidosanal for treatment of Haemorrhoids, Backed with Clinical Studies

    Ruby Khatun Khatun16 April 2018 10:16 AM IST
    Delhi: Next Gen Pharma India Pvt. Ltd. (Next Gen Pharma) is a speciality pharma startup offering niche products/solutions backed by sound evidence and...
    Bristol-Myers Squibb collaborates with Harvard for new fibrosis research

    Bristol-Myers Squibb collaborates with Harvard for new fibrosis research

    Ruby Khatun Khatun16 April 2018 10:00 AM IST
    Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announced a research collaboration to discover and...
    Orchard Therapeutics acquires GSKs rare disease gene therapy portfolio

    Orchard Therapeutics acquires GSK's rare disease gene therapy portfolio

    Ruby Khatun Khatun16 April 2018 9:45 AM IST
    GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease...
    Canadian pharmacy to be fined millions for illegal imports

    Canadian pharmacy to be fined millions for illegal imports

    Ruby Khatun Khatun16 April 2018 9:30 AM IST
    An online pharmacy that bills itself as Canada's largest is expected to be fined USD 34 million for importing counterfeit cancer drugs and other...
    Form panel to disburse medical claim under CGHS: SC to Centre

    Form panel to disburse medical claim under CGHS: SC to Centre

    Ruby Khatun Khatun15 April 2018 10:45 AM IST
    New Delhi: In a bid to protect retired public servants from "unnecessary harassment" in claiming reimbursements under the Central Government Health...
    Mylan seeks deal for German Mercks consumer products unit: sources

    Mylan seeks deal for German Merck's consumer products unit: sources

    Ruby Khatun Khatun15 April 2018 10:15 AM IST
    FRANKFURT/NEW YORK: Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA’s consumer health business after other bidders failed...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok